|
Argatroban is an anticoagulant that is a little molecule direct thrombin inhibitor. Around 2000, argatroban was licensed per FDA for prophylaxis or coarse of action of thrombosis in patients with heparin-induced thrombocytopenia. Within 2002, it was approved for apply when you took percutaneous coronary interventions in patients who use at times or even at chance for getting HIT.
Argatroban is given intravenously. Argatroban is metabolized in the liver and has a half life of astir Fifty proceedings. These are monitored by PTT. Because of its hepatic metabolism, it can be utilized inside patients using nephritic disfunction. (This is around direct contrast to lepirudin, a straight thrombin inhibitor that is primarily renally cleared).
These are made by GlaxoSmithKline.
|